KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma

Research output: Contribution to journalArticlepeer-review

35 Scopus citations
Original languageEnglish
Pages (from-to)e29-e31
JournalJournal of Thoracic Oncology
Volume13
Issue number3
DOIs
StatePublished - Mar 2018
Externally publishedYes

Cite this